Merck faces jury trial over Gardasil cancer vaccine marketing
Merck & Co (NYSE:MRK)., the second-largest U.S. drugmaker by revenue, is facing a jury trial over accusations that it ...
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial
Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
Analysts Issue Forecasts for MRK FY2029 Earnings
Analysts at Leerink Partnrs issued their FY2029 EPS estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Friday, January 24th. Leerink Partnrs analyst D.
Optimistic Buy Rating for Merck & Co. Driven by Winrevair Projections and Financial Strength
In a report released on January 24, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...
5 key health topics to watch at RFK Jr.'s Senate confirmation hearings
Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as Trump’s nominee for health secretary.